CTC1 (Conserved Telomere Maintenance Component 1) encodes a essential protein component of the CST complex (CTC1-STN1-TEN1), which plays critical roles in telomere replication, telomere length maintenance, and genome stability. Mutations in CTC1 are causative for Coats Plus syndrome, a rare disorder characterized by telomere dysfunction, neurodegeneration, and multi-organ involvement. Research increasingly links CTC1 and CST complex dysfunction to broader neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and ataxias. [1]
CTC1 encodes a 1,228-amino acid protein that functions as the largest subunit of the CST complex. This complex binds single-stranded telomeric and subtelomeric DNA to facilitate replication of the telomere ends. CTC1 mutations lead to telomere shortening and dysfunction, causing a spectrum of diseases known as telomere biology disorders. The gene is located on chromosome 16p13.3 and is widely expressed, with high levels in proliferative tissues. [2]
| Attribute | Value | [3]
|-----------|-------| [4]
| Symbol | CTC1 | [5]
| Full Name | Conserved Telomere Maintenance Component 1 | [6]
| Chromosomal Location | 16p13.3 |
| NCBI Gene ID | 80224 |
| OMIM | 613129 |
| Ensembl ID | ENSG00000107854 |
| UniProt ID | Q2NKJ8 |
| Expression | Ubiquitous; highest in testis, bone marrow, thymus |
The CTC1 protein contains multiple domains:
The CST complex (CTC1-STN1-TEN1) performs essential telomeric functions:
CTC1 mutations cause Coats Plus syndrome, characterized by:
CTC1 mutations contribute to cerebellar degeneration through:
Links between CTC1 and AD include:
Potential PD connections:
CTC1 interacts with:
Potential therapeutic strategies:
The study of Ctc1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Gu, P., & Chang, S. (2013). Functional characterization of human CTC1 in telomere maintenance. J Biol Chem. 2013. ↩︎
Armanios, M., & Blackburn, E.H. (2012). The telomere syndromes. Nat Rev Genet. 2012. ↩︎
Saretzki, G. (2003). Telomerase, telomeres and aging in Alzheimer's disease. J Alzheimer's Dis. 2003. ↩︎